ArticleCancers2021

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.

Ymera Pignochino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.